Consumption of benzodiazepine anxiolytics during the COVID-19 pandemic: a remote study with university students

• Autor(a) principal: Bruna Andrade Fontes
• Data de Publicação: 2022
• Outros Autores: Pablo Mateus dos Santos Jacinto, Renan Vieira de Santana Rocha
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Sapienza (Curitiba)
• DOI: 10.51798/sijis.v3i1.203
• Texto Completo: https://journals.sapienzaeditorial.com/index.php/SIJIS/article/view/203
• topic: Ansiolíticos; Benzodiazepínicos; Pandemia; COVID-19; Saúde do Estudante; Anxiolytics; Benzodiazepines; Pandemic; COVID-19; Student Health

Problems associated with anxieties and the sleep-wake cycle are common in the Brazilian population. In this pandemic, however, a possible increase in these cases is suspected, especially the population of Brazilian university students. The present study therefore intends to collect and analyze data about the consumption of benzodiazepine anxiolytics by university students during the COVID-19 pandemic period, enabling the construction of a focused epidemiological profile of this population. This is an on-line Survey type study, whose target audience was university students from Bahia, who voluntarily participated in the research. The results indicate a 25% increase in the number of university students who started using benzodiazepine anxiolytics during the COVID-19 pandemic, and that 8% of them self-medicate, evidencing the need for health actions by educational institutions higher education that, if neglected, can result in problems such as mental illness, conflicts in interpersonal relationships and dropout from the university environment.